Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Up 65.0% in January

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 2,571 shares, an increase of 65.0% from the December 31st total of 1,558 shares. Based on an average daily trading volume, of 10,271 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.1% of the shares of the company are sold short. Approximately 0.1% of the shares of the company are sold short. Based on an average daily trading volume, of 10,271 shares, the days-to-cover ratio is presently 0.3 days.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Jane Street Group LLC grew its position in Fidelity Disruptive Medicine ETF by 0.8% during the first quarter. Jane Street Group LLC now owns 66,382 shares of the company’s stock worth $1,567,000 after buying an additional 499 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in Fidelity Disruptive Medicine ETF by 4.6% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 714,991 shares of the company’s stock valued at $19,712,000 after acquiring an additional 31,629 shares in the last quarter. BXM Wealth LLC bought a new stake in shares of Fidelity Disruptive Medicine ETF in the 4th quarter worth approximately $243,000. Finally, Glass Jacobson Investment Advisors llc grew its holdings in shares of Fidelity Disruptive Medicine ETF by 44.0% during the 4th quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock worth $34,000 after purchasing an additional 385 shares in the last quarter.

Fidelity Disruptive Medicine ETF Price Performance

Shares of Fidelity Disruptive Medicine ETF stock traded down $0.31 during midday trading on Friday, hitting $26.67. The company had a trading volume of 3,796 shares, compared to its average volume of 8,795. Fidelity Disruptive Medicine ETF has a 1-year low of $20.69 and a 1-year high of $29.07. The business’s 50 day simple moving average is $27.69 and its two-hundred day simple moving average is $26.00. The stock has a market cap of $61.34 million, a PE ratio of 41.33 and a beta of 1.00.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.